DOI QR코드

DOI QR Code

대두 chiro-inositol의 혈당강하효과

Effect of chiro-inositol from Soybean on Reducing Hyperglycemia and Its Role for Nutraceutic Supplement for Insulin Resistance

  • 홍용근 (경상대학교 응용생명과학원 및 자연과학대학 생명과학부 생화학과) ;
  • 박윤배 (경상대학교 응용생명과학원 및 자연과학대학 생명과학부 생화학과)
  • Hong Yonggeun (Department of Biochemistry, Division of Life Science, College of Natural Sciences, Graduate School of Applied Life Science, Gyeongsang National University) ;
  • Pak Yunbae (Department of Biochemistry, Division of Life Science, College of Natural Sciences, Graduate School of Applied Life Science, Gyeongsang National University)
  • 발행 : 2005.04.01

초록

본 연구는 혈당강하효과를 갖는 chiro-inositol을 다량 함유하고 있는 식품이나 식용물질을 탐색하여 선발하고, 선택된 식품이나 식용물질에서 chiro-inositol을 분리$ {\cdot}$정제하여 정제된 chiro-inositol로 동물실험을 실시하여 혈당강하효과를 증명하였다. 약 300여종의 식품 및 식용물질을 HPLC로 분석한 결과 식품으로 안전한 대두 부산물인 탈지대두와 두부 순물에서 chiro-inositol의 함량이 각각 6.75 mg/g, 20mg/kg로 조사되어 선택되었고, chiro-inositol의 순도가 $90\%$ 이상(w/w)인 chiro-inositol의 추출물을 이용하여 동물실험을 통한 혈당강하효과를 조사하였다. 그 결과, STZ로 유발된 고혈당 쥐에 경구 투여시, 약 $40\%$의 강한 혈당강하 효과를 나타내었으며 지속시간은 약 12시간이었고, 인슐린과 복합처리 했을 때 상승작용(synergy)을 나타내었으며, 저혈당증으로 전혀 발전되지 않았다.

Studies with diabetic mammalian systems showed that chiro-inositol administration decreased blood glucose levels. We investigated which foodstuffs contain large amounts of chiro-inositol by surveying vegetables, edible plants and other staples in an effort to explore the nutritional or therapeutic supplements of chiro-inositol for diabetic patients. In the course of our investigation, we found that soybean and soybean derivatives have high chiro-inositol levels (upto 20 mg/g). The purified chiro-inositol from the soybean was then tested for reducing hyperglycemia by administrating the chiro-inositol in streptozotocin-treated diabetic rats. The results showed that the intragastric administration of 50 mg chiro-inositol/kg BW lowered hyperglycemia by $40\%$ and that the effect was sustained for approximately 12 hr.

키워드

참고문헌

  1. Farese, R. V., M. L. Standaert, K. Yamada, L. C. Huang, C. Zhang, D. R. Cooper, Z. Wang, S. Suzuki, T. Toyota and J. Lamer. 1994. Defective insulin-induced activation of glycerol-3-phosphate acyltransferase (G3PAT) by a chiroinositolcontaining insulin mediator in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki (GK) rats. Proc Natl Acad Sci USA 91, 11040-11044
  2. Hong, Y and Y. Pak. 1999. Identification of chiro-inositolcontaining phospholipids and changes in their metabolism upon salt stress in soybean seedlings. Phytochemistry 51, 861-866 https://doi.org/10.1016/S0031-9422(99)00127-2
  3. Huang, L. C., M. C. Fonteles, D. B. Houston, C. Zhang and J. Larner. 1993. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo. Endocrinol 132, 652-657 https://doi.org/10.1210/en.132.2.652
  4. Kennigton, A. S., C. R. Hill, J. Craig, C. Bogardus, I. Raz, H. K. Ortmeyer, B. C. Hansen, G. Romero and J. Lamer. 1990. Low urinary chiroinositol excretion in non-insulin-dependent diabetes mellitus. New Eng J Med 323, 373-378 https://doi.org/10.1056/NEJM199008093230603
  5. Larner, J. 1994. Multiple pathways in insulin signaling-fitting the covalent and allosteric puzzle pieces together. Endocrine J 2, 167-171
  6. Larner, J. 2001. D-chiro-inositol in insulin action and insulin resistance. IUBMB Life 51, 139-148 https://doi.org/10.1080/152165401753544205
  7. Larner, J., G. Calasko, K. Cheong, A. A. DePaoli-Roach, L. Huang, P. Daggy and J. Kellogg. 1979. Generation by insulin of a chemical mediator that controls protein phosphorylation and dephosphorylation.. Science 206, 1408-1410 https://doi.org/10.1126/science.228395
  8. Larner, J., L. C. Huang, C. F. W. Schwartz, A. S. Oswald, T. Y. Shen, M. Kinter, G. Tang and K. Zeller. 1988. Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphatase contains galactosamine and D-chiroinositol. Biochem Biophys Res Commun 151, 1416-1426 https://doi.org/10.1016/S0006-291X(88)80520-5
  9. Ortmeyer, H. K, L. C. Huang, L. Zhang, B. C. Hansen and J. Lamer. 1993. Acute effects of D-chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistance rhesus monkeys. Endocrinol 132, 646-651 https://doi.org/10.1210/en.132.2.646
  10. Ostlund, R. E. Jr, J. B. McGill, I. Herskowitz, D. M. Kipnis, J. V. Santiago and W. D. Sherman. 1993. D-chiroinositol metabolism in diabetes mellitus. Proc Nail Acad Sci USA 90, 9988-9992
  11. Pak, Y., Y. Hong, S. Kim, T. Piccariello, R. V. Farese and J. Larner. 1998. In vivo chiro-inositol metabolism in the rat: A defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro-[$^3H$] into phospholipid in the Goto-Kakizaki (G.K.) rat. Mol Cells 8, 301-309
  12. Pak, Y., L. C. Huang, K. J. Lilley and J. Larner. 1992. In vivo conversion of [$^3H$]myoinositol to [$^3H$]chiroinositol in rat tissues. J Biol Chem 267, 16904-16910
  13. Pak, Y. and J. Larner. 1992. Identification and characterization of chiroinositol- containing phospholipids from bovine liver. Biochem Biophys Res Commun 184, 1042-1047 https://doi.org/10.1016/0006-291X(92)90696-I
  14. Pak, Y., C. R. Paule, Y. D. Bao, L. C. Huang and J. Larner. 1993. Insulin stimulates the bioxynthesis of chiroinositol-ontaining phospholipids in a rat fibroblast line expressing the human insulin receptor. Proc Natl Acad Sci USA 90, 7759-7763
  15. Romero, G. and J. Larner. 1993. Insulin mediators and the mechanism of insulin action. Adv Pharm 24, 21-59 https://doi.org/10.1016/S1054-3589(08)60932-1
  16. Romero, G., L. Luttrell, A. Rogol, K. Zeller, E. Hewlett and J. Larner. 1998. Phosphatidylinositol-glycan anchors of membrane proteins: Potential precursors of insulin mediators. Science 240, 509-511
  17. Saltiel, A. R. 1994. The paradoxical regulation of protein phosphorylation in insulin action. FASEB J 8, 1034-1040
  18. Suzuki,S., H. Kawasaki, Y. Satoh, M. Ohtomo, M. Hirai, A. Hirai, S. Hirai, M. Onoda, M. Matsumoto, Y. Hinodio, H. Akai and T. Toyota. 1994. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese Type II diabetes. Diabetes Care 17, 1465-1468 https://doi.org/10.2337/diacare.17.12.1465
  19. Suzuki, S., T. Toyota, S. Tamura, K. Kikuchi, S. Tsuiki, L. Huang, C. Villar-Palasi, J. Larner and Y. Goto. 1987. ATPMn2+ stimulates the generation of a putative mediator of insulin action. J Biol Chem 262, 3199-3204
  20. Taylor, S. I., D. Accili and Y. Imai. 1994. Insulin resistance or insulin deficiency: Which is the primary cause of NIDDM? Diabetes 43, 735-740 https://doi.org/10.2337/diab.43.6.735

피인용 문헌

  1. Chemical Characteristics of Cell Wall in Pinus thunbergii Parl. Grown with High Salinity vol.47, pp.4, 2015, https://doi.org/10.7584/ktappi.2015.47.4.144
  2. Effects of steeping condition and salinity stress on quality properties in germinated black soybean vol.21, pp.4, 2014, https://doi.org/10.11002/kjfp.2014.21.4.500